12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AQX-1125: Phase I started

Aquinox began a double-blind, placebo-controlled, European Phase I trial to evaluate single- and multiple-ascending doses of oral...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >